BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 29118205)

  • 1. Epigenetic Etiology of Intellectual Disability.
    Iwase S; Bérubé NG; Zhou Z; Kasri NN; Battaglioli E; Scandaglia M; Barco A
    J Neurosci; 2017 Nov; 37(45):10773-10782. PubMed ID: 29118205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic factors in intellectual disability: the Rubinstein-Taybi syndrome as a paradigm of neurodevelopmental disorder with epigenetic origin.
    Lopez-Atalaya JP; Valor LM; Barco A
    Prog Mol Biol Transl Sci; 2014; 128():139-76. PubMed ID: 25410544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant epigenetic landscape in intellectual disability.
    Sanchez-Mut JV; Huertas D; Esteller M
    Prog Brain Res; 2012; 197():53-71. PubMed ID: 22541288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic syndromes caused by mutations in epigenetic genes.
    Berdasco M; Esteller M
    Hum Genet; 2013 Apr; 132(4):359-83. PubMed ID: 23370504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of spurious transcription to intellectual disability disorders.
    Scandaglia M; Barco A
    J Med Genet; 2019 Aug; 56(8):491-498. PubMed ID: 30745423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability.
    Kleefstra T; Kramer JM; Neveling K; Willemsen MH; Koemans TS; Vissers LE; Wissink-Lindhout W; Fenckova M; van den Akker WM; Kasri NN; Nillesen WM; Prescott T; Clark RD; Devriendt K; van Reeuwijk J; de Brouwer AP; Gilissen C; Zhou H; Brunner HG; Veltman JA; Schenck A; van Bokhoven H
    Am J Hum Genet; 2012 Jul; 91(1):73-82. PubMed ID: 22726846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Where Environment Meets Cognition: A Focus on Two Developmental Intellectual Disability Disorders.
    De Toma I; Manubens-Gil L; Ossowski S; Dierssen M
    Neural Plast; 2016; 2016():4235898. PubMed ID: 27547454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and cellular events linking variants in the histone demethylase KDM5C to the intellectual disability disorder Claes-Jensen syndrome.
    Hatch HAM; Secombe J
    FEBS J; 2022 Dec; 289(24):7776-7787. PubMed ID: 34536985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental disorders with intellectual disability driven by chromatin dysregulation: Clinical overlaps and molecular mechanisms.
    Larizza L; Finelli P
    Clin Genet; 2019 Feb; 95(2):231-240. PubMed ID: 29672823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mendelian disorders of the epigenetic machinery: postnatal malleability and therapeutic prospects.
    Fahrner JA; Bjornsson HT
    Hum Mol Genet; 2019 Nov; 28(R2):R254-R264. PubMed ID: 31595951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic mechanisms of mental retardation.
    Schaefer A; Tarakhovsky A; Greengard P
    Prog Drug Res; 2011; 67():125-46. PubMed ID: 21141728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of genetics in the establishment and maintenance of the epigenome.
    Huidobro C; Fernandez AF; Fraga MF
    Cell Mol Life Sci; 2013 May; 70(9):1543-73. PubMed ID: 23474979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soma-to-germline transformation in chromatin-linked neurodevelopmental disorders?
    Bonefas KM; Iwase S
    FEBS J; 2022 Apr; 289(8):2301-2317. PubMed ID: 34514717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone and DNA modifications in mental retardation.
    Iwase S; Shi Y
    Prog Drug Res; 2011; 67():147-73. PubMed ID: 21141729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of
    Gao ZJ; Jiang Q; Chen XL; Chen Q; Ji XN; Mao YY; Feng S; Dong JJ; Xu KM
    Zhonghua Yi Xue Za Zhi; 2018 Nov; 98(42):3426-3432. PubMed ID: 30440138
    [No Abstract]   [Full Text] [Related]  

  • 16. Epigenetic Causes of Overgrowth Syndromes.
    Lui JC; Baron J
    J Clin Endocrinol Metab; 2024 Jan; 109(2):312-320. PubMed ID: 37450557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reprogramming of the epigenome in neurodevelopmental disorders.
    Wilson KD; Porter EG; Garcia BA
    Crit Rev Biochem Mol Biol; 2022 Feb; 57(1):73-112. PubMed ID: 34601997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral blood epi-signature of Claes-Jensen syndrome enables sensitive and specific identification of patients and healthy carriers with pathogenic mutations in
    Schenkel LC; Aref-Eshghi E; Skinner C; Ainsworth P; Lin H; Paré G; Rodenhiser DI; Schwartz C; Sadikovic B
    Clin Epigenetics; 2018; 10():21. PubMed ID: 29456765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of nucleosome remodeling in neurodevelopmental and intellectual disability disorders.
    López AJ; Wood MA
    Front Behav Neurosci; 2015; 9():100. PubMed ID: 25954173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rubinstein-Taybi Syndrome and Epigenetic Alterations.
    Korzus E
    Adv Exp Med Biol; 2017; 978():39-62. PubMed ID: 28523540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.